Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Am J Prev Med. 2017 Oct 2;53(6):781–790. doi: 10.1016/j.amepre.2017.08.002

Table 2.

Smoking Cessation Outcomes by Measure and Time Period

Follow-up survey/Measure Smoking status imputeda Complete casesb

Interv
ention
(%)
Cont
rol
(%)
RR (95%
CI)
Interv
ention
(%)
Cont
rol
(%)
RR (95%
CI)
n=250 n=24
7
(unadjust
ed)
(unadjust
ed)
Primary outcome
  3-month
  Biochemically confirmed 7-day point prevalence abstinence 39 (15.60) 27 (10.93) 1.51 (0.89–2.55) 39 (19.90) 27 (13.04) 1.53 (0.97–2.39)
  Biochemically confirmed 30-day point prevalence abstinence 32 (12.80) 26 (10.53) 1.12 (0.83–1.52) 32 (16.33) 26 (12.56) 1.30 (0.81–2.10)
Secondary outcome
  1-month
    Not smoked in past 7 days 72 (28.80) 39 (15.79) 2.16 (1.39–3.34)** 72 (34.78) 39 (17.49) 1.64 (1.25–2.15)***
    Not smoked in past 30 days 31 (12.40) 19 (7.69) 1.70 (0.93–3.10) 31 (14.90) 19 (8.56) 1.41 (0.97–2.03)
  3-month
    Not smoked in past 7 days 88 (35.20) 56 (22.67) 1.85 (1.25–2.75)** 88 (44.90) 56 (27.05) 1.47 (1.21–1.78)***
    Not smoked in past 30 days 73(29. 20) 47 (19.03) 1.76 (1.15–2.67)** 73 (37.44) 47 (22.71) 1.41 (1.161.71)***
  6-month
    Not smoked in past 7 days 73 (29.20) 63 (25.51) 1.21 (0.81–1.79) 73 (41.95) 63 (35.20) 1.15 (0.93–1.44)
    Not smoked in past 30 days 60 (24.00) 57 (23.08) 1.05 (0.70–1.59) 60 (33.52) 57 (31.49) 1.05 (0.84–1.31)
  Late pregnancy
    Not smoked in past 7 days 86 (34.40) 53 (21.46) 1.35 (1.14–1.61)*** 86 (46.49) 53 (28.19) 1.46 (1.20–1.78)***
    Not smoked in past 30 days 69 (27.60) 46 (18.62) 1.27 (1.06–1.52)** 69 (37.10) 46 (24.21) 1.34 (1.09–1.64)**
  Postpartum
  Not smoked in past 7 days 41 (16.40) 42 (17.00) 0.98 (0.77–1.24) 41 (35.96) 42 (33.33) 1.12 (0.66–1.91)
  Not smoked in past 30 days 35 (14.00) 38 (15.38) 0.95 (0.73–1.22) 35 (29.66) 38 (30.16) 0.98 (0.56–1.69)

Note: Boldface indicates statistical significance (*p<0.05; **p<0.01; ***p<0.001).

a

Missing data were imputed to indicate smoking; The full sample was used in the analysis.

b

No imputation of missing data; Only complete cases were used in this analysis.

RR, relative risk